Kazuharu Kai

2.8k total citations
38 papers, 1.2k citations indexed

About

Kazuharu Kai is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kazuharu Kai has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 13 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kazuharu Kai's work include Cancer-related Molecular Pathways (10 papers), Cancer Cells and Metastasis (9 papers) and Advanced Breast Cancer Therapies (5 papers). Kazuharu Kai is often cited by papers focused on Cancer-related Molecular Pathways (10 papers), Cancer Cells and Metastasis (9 papers) and Advanced Breast Cancer Therapies (5 papers). Kazuharu Kai collaborates with scholars based in Japan, United States and United Kingdom. Kazuharu Kai's co-authors include Hideyuki Saya, Subrata Sen, Naoto T. Ueno, Hirotaka Iwase, Yoshimi Arima, Rachel L. Dittmar, Takayuki Iwamoto, Yutaka Yamamoto, Weijia Zhang and Lidong Qin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Kazuharu Kai

38 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kazuharu Kai Japan	18	577	487	443	187	178	38	1.2k
Franck Assayag France	17	668 1.2×	549 1.1×	388 0.9×	227 1.2×	116 0.7×	35	1.3k
James E. Verdone United States	13	603 1.0×	477 1.0×	421 1.0×	198 1.1×	205 1.2×	18	1.1k
André Filipe Vieira Portugal	18	741 1.3×	793 1.6×	456 1.0×	95 0.5×	287 1.6×	29	1.5k
Ernst J.A. Steller Netherlands	15	741 1.3×	717 1.5×	424 1.0×	228 1.2×	141 0.8×	20	1.5k
Jason J. Christiansen United States	7	585 1.0×	612 1.3×	271 0.6×	115 0.6×	220 1.2×	8	1.2k
Ludmilla de Plater France	13	458 0.8×	405 0.8×	249 0.6×	149 0.8×	155 0.9×	23	934
Yoko S. DeRose United States	9	699 1.2×	439 0.9×	342 0.8×	165 0.9×	90 0.5×	10	1.1k
Caroline Delmas France	22	408 0.7×	794 1.6×	433 1.0×	104 0.6×	160 0.9×	37	1.4k
Kam Sprott United States	12	376 0.7×	756 1.6×	276 0.6×	127 0.7×	130 0.7×	31	1.2k
Vanesa L. Silvestri Italy	9	824 1.4×	679 1.4×	450 1.0×	186 1.0×	184 1.0×	10	1.4k

Countries citing papers authored by Kazuharu Kai

Since Specialization

Citations

This map shows the geographic impact of Kazuharu Kai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuharu Kai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuharu Kai more than expected).

Fields of papers citing papers by Kazuharu Kai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuharu Kai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuharu Kai. The network helps show where Kazuharu Kai may publish in the future.

Co-authorship network of co-authors of Kazuharu Kai

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuharu Kai. A scholar is included among the top collaborators of Kazuharu Kai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuharu Kai. Kazuharu Kai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shah, Nina, Miguel‐Angel Perales, Cameron J. Turtle, et al.. (2021). Phase I Study Protocol: NKTR-255 as Monotherapy or Combined with Daratumumab or Rituximab in Hematologic Malignancies. Future Oncology. 17(27). 3549–3560. 17 indexed citations

Kai, Kazuharu, Takayuki Iwamoto, Dongwei Zhang, et al.. (2018). CSF-1/CSF-1R axis is associated with epithelial/mesenchymal hybrid phenotype in epithelial-like inflammatory breast cancer. Scientific Reports. 8(1). 9427–9427. 30 indexed citations

Sasai, Kaori, Warapen Treekitkarnmongkol, Kazuharu Kai, Hiroshi Katayama, & Subrata Sen. (2016). Functional Significance of Aurora Kinases–p53 Protein Family Interactions in Cancer. Frontiers in Oncology. 6. 247–247. 40 indexed citations

Treekitkarnmongkol, Warapen, Hiroshi Katayama, Kazuharu Kai, et al.. (2016). Aurora kinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancer. Carcinogenesis. 37(12). bgw097–bgw097. 22 indexed citations

Kai, Kazuharu, Kimie Kondo, Xiaoping Wang, et al.. (2015). Antitumor Activity of KW-2450 against Triple-Negative Breast Cancer by Inhibiting Aurora A and B Kinases. Molecular Cancer Therapeutics. 14(12). 2687–2699. 17 indexed citations

Kogawa, Takahiro, Diane D. Liu, Tamer M. Fouad, et al.. (2014). Clinical Characteristics and Outcome of Bone-Only Metastasis in Inflammatory and Noninflammatory Breast Cancers. Clinical Breast Cancer. 15(1). 37–42. 5 indexed citations

Kai, Kazuharu, Takayuki Iwamoto, Takashi Kobayashi, et al.. (2013). Ink4a/Arf−/− and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f− quiescent cells. Oncogene. 33(4). 440–448. 8 indexed citations

Zhang, Weijia, Kazuharu Kai, Naoto T. Ueno, & Lidong Qin. (2013). A Brief Review of the Biophysical Hallmarks of Metastatic Cancer Cells. PubMed. 1(2). 59–66. 16 indexed citations

Iwamoto, Takayuki, Peng Liu, Yong Shen, et al.. (2012). Abstract PD03-08: Statin use and improved outcome in primary inflammatory breast cancer: retrospective cohort study. Cancer Research. 72(24_Supplement). PD03–8. 1 indexed citations

10.

Zhang, Weijia, Kazuharu Kai, Dong Soon Choi, et al.. (2012). Microfluidics separation reveals the stem-cell–like deformability of tumor-initiating cells. Proceedings of the National Academy of Sciences. 109(46). 18707–18712. 162 indexed citations

11.

Sugihara, Eiji, Takatsune Shimizu, Kensuke Kojima, et al.. (2011). Ink4a and Arf are crucial factors in the determination of the cell of origin and the therapeutic sensitivity of Myc-induced mouse lymphoid tumor. Oncogene. 31(23). 2849–2861. 23 indexed citations

12.

Arima, Yoshimi, Naoki Hayashi, Hidemi Hayashi, et al.. (2011). Loss of p16 expression is associated with the stem cell characteristics of surface markers and therapeutic resistance in estrogen receptor‐negative breast cancer. International Journal of Cancer. 130(11). 2568–2579. 59 indexed citations

13.

Kai, Kazuharu, Osamu Nagano, Eiji Sugihara, et al.. (2009). Maintenance of HCT116 colon cancer cell line conforms to a stochastic model but not a cancer stem cell model. Cancer Science. 100(12). 2275–2282. 45 indexed citations

14.

Ishimoto, Takatsugu, Hiroko Oshima, Masanobu Oshima, et al.. (2009). CD44⁺ slow‐cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E₂ in gastric tumorigenesis. Cancer Science. 101(3). 673–678. 114 indexed citations

15.

Kai, Kazuharu, Yoshimi Arima, Toshio Kamiya, & Hideyuki Saya. (2009). Breast cancer stem cells. Breast Cancer. 17(2). 80–85. 77 indexed citations

16.

Kai, Kazuharu, Nobuyuki Arima, Haruhiko Miyayama, et al.. (2008). Pathological lymph node involvement at surgery is a significant predictive factor of recurrence in locally advanced breast cancer treated with concomitant epirubicin–docetaxel neoadjuvant chemotherapy: a cohort study. Breast Cancer. 16(1). 42–48. 7 indexed citations

17.

Yamamoto, Yutaka, et al.. (2007). Aromatase inhibitor-induced joint symptom in patients with breast cancer. Journal of Clinical Oncology. 25(18_suppl). 11070–11070. 2 indexed citations

18.

Beppu, Toru, Ryuichi Karashima, Shinichi Sugiyama, et al.. (2006). A Successfully Resected Case of Adult Hepatoblastoma with Hepatitis C. The Japanese Journal of Gastroenterological Surgery. 39(1). 72–77. 1 indexed citations

19.

Kai, Kazuharu, Reiki Nishimura, Nobuyuki Arima, Haruhiko Miyayama, & Hirotaka Iwase. (2006). p53 expression status is a significant molecular marker in predicting the time to endocrine therapy failure in recurrent breast cancer: a cohort study. International Journal of Clinical Oncology. 11(6). 426–433. 32 indexed citations

20.

Takahashi, Masafumi, Toru Beppu, Koichi Doi, et al.. (2003). [Multidisciplinary treatment for hepatocellular carcinoma invading the stomach].. PubMed. 30(11). 1741–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact